BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saracyn M, Zdanowski R, Brytan M, Kade G, Nowak Z, Patera J, Dyrla P, Gil J, Wańkowicz Z. D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Med Sci Monit 2015;21:1469-77. [PMID: 26009004 DOI: 10.12659/MSM.893291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Reference Citation Analysis]
2 Park S, Zhang T, Wu X, Qiu JY. A mixture of mulberry and silk amino acids protected against D-galactosamine induced acute liver damage by attenuating oxidative stress and inflammation in HepG2 cells and rats. Exp Ther Med 2020;19:3611-9. [PMID: 32346425 DOI: 10.3892/etm.2020.8636] [Reference Citation Analysis]
3 Sepehrinezhad A, Shahbazi A, Sahab Negah S, Joghataei MT, Larsen FS. Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy. Toxicol Rep 2021;8:962-70. [PMID: 34026559 DOI: 10.1016/j.toxrep.2021.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Atwa A, Hegazy R, Mohsen R, Yassin N, Kenawy S. Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats. Open Access Maced J Med Sci 2017;5:880-92. [PMID: 29362613 DOI: 10.3889/oamjms.2017.173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]